Gastroenterology - European Medical Journal

Continue

Gastroenterology

Filter
7 Mins
11 Dec 2018

Prevention of Infantile Colic Using Probiotics

Infantile colic is a frustrating impasse that affects up to 20% of infants. Even though its pathogenesis is currently unknown, some…
6 Mins
4 Sep 2018

Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography Findings in the Postorthotopic Liver Transplant Population

Magnetic resonance cholangiopancreatography (MRCP) is an important diagnostic tool in evaluating patients with biliary laboratory abnormalities after…
9 Mins
28 Aug 2018

Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…
9 Mins
28 Aug 2018

Individualised Care for Crohn's Disease: Evolving Approaches for a Progressive Disease

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.
9 Mins
12 Jun 2018

Keep CALM and Use Biomarkers in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) has a dramatic impact on patients and their families, as well as on society as a whole due to its significant economic…
8 Mins
7 Jun 2018

Delivering Precision Medicine and Patient-Centred Care Through a Multidisciplinary Approach

The current treatment strategy for patients with inflammatory bowel disease (IBD) aims to enable physicians to deliver optimal care and to improve the…
9 Mins
7 Jun 2018

Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…
7 Mins
7 Jun 2018

Editor's Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker

Gastric cancer is the second most common cause of cancer-related deaths worldwide, and the 5-year overall survival rate for advanced gastric cancer is ≤25%.